Stocktwits on MSN2h
Merck Enters $2B License Agreement With China-Based Hengrui Pharma For Heart Disease Drug: Retail’s Unswayed
Merck & Co., Inc. (MRK) said on Tuesday that it hasentered into an exclusive license agreement with China-based Jiangsu ...
BioSpace6h
Trump Doubles Down on Pharma Tariff Threats
President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...
Pharmaceutical Technology8h
Trump tariffs drive pharma manufacturing to US but risk inflation and disruption
Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...
GlobeSt23h
Johnson & Johnson Commits $55B to U.S. Healthcare Expansion
According to an announcement by the pharmaceutical company, Johnson & Johnson (JNJ) will invest over $55 billion in various ...
mPath Health of Winston-Salem chosen for second cohort of CancerX accelerator
The CancerX Accelerator, hosted by Moffitt Cancer Center, has selected 14 startups for its second cohort, focusing on ...
pharmaphorum19h
Merck confirms its interest in buying SpringWorks
German chemical and pharma group Merck KGaA has acknowledged that it is in talks to buy US biotech SpringWorks, but cautioned there is no guarantee a deal will be forthcoming. Merck said in a ...
Charlotte Observer23h
With his father watching, Dré Bly’s son emerges at UNC Pro Day: ‘That’s what we do’
“Like I was saying, Josh Downs is his first cousin, and you combine that DNA with my DNA, we got it. It’s just a matter of when you’re able to display it.” Real-time updates and all local ...